Martell Robert has filed 3 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 12500 shares of Indaptus Therapeutics, Inc. ($INDP) on June 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Martell Robert | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,013,901 | 9999.99% | 0.10% |
| June 6, 2024 | Indaptus Therapeutics, Inc. | $INDP | Martell Robert | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 8,401,047 | 9999.99% | 0.15% |
| Jan. 20, 2023 | CURIS INC | $CRIS | Martell Robert | Head of Research & Development | A | Employee stock option (right to buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |